32431588|t|Gut Microbiome-Modified Polyphenolic Compounds Inhibit alpha-Synuclein Seeding and Spreading in alpha-Synucleinopathies.
32431588|a|Misfolding, aggregation and deposition of alpha-synuclein (alpha-syn) are major pathologic characteristics of Parkinson's disease (PD) and the related synucleinopathy, multiple system atrophy (MSA). The spread of alpha-syn pathology across brain regions is thought to play a key role in the onset and progression of clinical phenotypes. Thus, there is increasing interest in developing strategies that target and attenuate alpha-syn aggregation and spread. Recent studies of brain-penetrating polyphenolic acids, namely, 3-hydroxybenzoic acid (3-HBA), 3,4-dihydroxybenzoic acid (3,4-diHBA), and 3-(3-hydroxyphenyl)propionic acid (3-HPPA) that are derived from gut microbiota metabolism of dietary polyphenols, show in vitro ability to effectively modulate alpha-syn misfolding, oligomerization, and mediate aggregated alpha-syn neurotoxicity. Here we investigate whether 3-HBA, 4-hydroxybenzoic acid (4-HBA), 3,4-diHBA, or 3-HPPA interfere with alpha-syn spreading in a cell-based system. Using HEK293 cells overexpressing alpha-syn-A53T-CFP/YFP, we assessed alpha-syn seeding activity using Fluorescence Resonance Energy Transfer (FRET) to detect and quantify alpha-syn aggregation. We demonstrated that 3-HPPA, 3,4-diHBA, 3-HBA, and 4-HBA significantly attenuated intracellular alpha-syn seeding aggregation. To determine whether our compounds could inhibit brain-derived seeding activity, we utilized insoluble alpha-syn extracted from post-mortem MSA or PD brain specimens. We found that 3-HPPA effectively attenuated MSA-induced aggregation of monomer into high molecular weight aggregates capable of inducing intracellular aggregation. Outcomes from our studies suggest interactions between gut microbiome and certain dietary factors may form the basis for effective therapies that modulate pathologic alpha-syn propagation. Collectively, our findings provide the basis for future developments of probiotic, prebiotic, or synbiotic approaches for modulating the onset and/or progression of alpha-synucleinopathies.
32431588	24	46	Polyphenolic Compounds	Chemical	-
32431588	55	70	alpha-Synuclein	Gene	6622
32431588	96	119	alpha-Synucleinopathies	Disease	MESH:D000080874
32431588	163	178	alpha-synuclein	Gene	6622
32431588	180	189	alpha-syn	Gene	6622
32431588	231	250	Parkinson's disease	Disease	MESH:D010300
32431588	252	254	PD	Disease	MESH:D010300
32431588	272	287	synucleinopathy	Disease	MESH:D000080874
32431588	289	312	multiple system atrophy	Disease	MESH:D019578
32431588	314	317	MSA	Disease	MESH:D019578
32431588	334	343	alpha-syn	Gene	6622
32431588	544	553	alpha-syn	Gene	6622
32431588	614	632	polyphenolic acids	Chemical	-
32431588	642	663	3-hydroxybenzoic acid	Chemical	MESH:C032948
32431588	665	670	3-HBA	Chemical	MESH:C032948
32431588	673	698	3,4-dihydroxybenzoic acid	Chemical	MESH:C009091
32431588	700	709	3,4-diHBA	Chemical	MESH:C009091
32431588	716	749	3-(3-hydroxyphenyl)propionic acid	Chemical	MESH:C038547
32431588	751	757	3-HPPA	Chemical	MESH:C038547
32431588	818	829	polyphenols	Chemical	MESH:D059808
32431588	877	886	alpha-syn	Gene	6622
32431588	939	948	alpha-syn	Gene	6622
32431588	949	962	neurotoxicity	Disease	MESH:D020258
32431588	992	997	3-HBA	Chemical	MESH:C032948
32431588	999	1020	4-hydroxybenzoic acid	Chemical	MESH:C038193
32431588	1022	1027	4-HBA	Chemical	MESH:C038193
32431588	1030	1039	3,4-diHBA	Chemical	MESH:C009091
32431588	1044	1050	3-HPPA	Chemical	MESH:C038547
32431588	1066	1075	alpha-syn	Gene	6622
32431588	1116	1122	HEK293	CellLine	CVCL:0045
32431588	1144	1153	alpha-syn	Gene	6622
32431588	1154	1158	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
32431588	1180	1189	alpha-syn	Gene	6622
32431588	1282	1291	alpha-syn	Gene	6622
32431588	1326	1332	3-HPPA	Chemical	MESH:C038547
32431588	1334	1343	3,4-diHBA	Chemical	MESH:C009091
32431588	1345	1350	3-HBA	Chemical	MESH:C032948
32431588	1356	1361	4-HBA	Chemical	MESH:C038193
32431588	1401	1410	alpha-syn	Gene	6622
32431588	1535	1544	alpha-syn	Gene	6622
32431588	1572	1575	MSA	Disease	MESH:D019578
32431588	1579	1581	PD	Disease	MESH:D010300
32431588	1613	1619	3-HPPA	Chemical	MESH:C038547
32431588	1643	1646	MSA	Disease	MESH:D019578
32431588	1929	1938	alpha-syn	Gene	6622
32431588	2117	2140	alpha-synucleinopathies	Disease	MESH:D000080874
32431588	Association	MESH:D019578	6622
32431588	Negative_Correlation	MESH:C009091	6622
32431588	Association	MESH:D020258	6622
32431588	Association	MESH:D000080874	6622
32431588	Association	MESH:C009091	MESH:D020258
32431588	Association	MESH:C032948	MESH:D020258
32431588	Negative_Correlation	MESH:C038547	MESH:D019578
32431588	Association	MESH:D010300	6622
32431588	Negative_Correlation	MESH:C032948	6622
32431588	Negative_Correlation	MESH:C038547	6622
32431588	Negative_Correlation	MESH:C038193	6622
32431588	Positive_Correlation	MESH:C038547	MESH:D020258

